COVID-related US-Mexico border closure may have fueled HIV spread
Closing the border separating San Diego and Tijuana, Mexico, during the COVID-19 pandemic didn’t stop drug tourism and may have increased the spread of HIV, concludes a study posted in The Lancet Regional Health Americas. From October 2020 to October 2021, a team led by University of California at San Diego (UCSD) researchers recruited 612 adults from […]
US geographic region results in vastly different anal cancer risk for people with HIV
A new study that followed a cohort of more than 110,000 people establishes significant disparities in the risk of anal cancer for people with HIV and for men who have sex with men with HIV, depending on the region of the country they live in. It’s known that people with HIV have the highest risk […]
Kaposi sarcoma discovery could facilitate drug development
Researchers at UNC Lineberger Comprehensive Cancer Center, after decades of research efforts, have developed a mouse model of Kaposi sarcoma that could be key to the development of new drugs to treat the disease. Kaposi sarcoma is a cancer that is the most common cancer in people living with HIV. The findings appeared in Cell […]
Study highlights heavy global burden of infectious diseases
A study published this week in The Lancet Infectious Diseases highlights the substantial impact of infectious diseases on global health. The analysis of data from 204 countries by researchers with the Institute for Health Metrics and Evaluation estimates that 85 pathogens accounted for 704 million disability-adjusted life years (DALYs)—the number of years lost from ill […]
Common HIV treatments may aid Alzheimer’s disease patients
Alzheimer’s disease (AD) currently afflicts nearly seven million people in the U.S. With this number expected to grow to nearly 13 million by 2050, the lack of meaningful therapies represents a major unmet medical need. Scientists at Sanford Burnham Prebys have now identified promising real-world links between common HIV drugs and a reduced incidence of […]
Scientists identify pro-aging ‘sugar signature’ in the blood of people living with HIV
The Wistar Institute’s associate professor Mohamed Abdel-Mohsen, Ph.D., along with his team and collaborators, has identified sugar abnormalities in the blood that may promote biological aging and inflammation in people living with HIV (PLWH). The findings, taken from a large data study comprising more than 1200 participants, are detailed in the new paper, “Immunoglobulin G […]
Immune key to chronic viral infections discovered
Australian researchers have discovered a previously unknown rogue immune cell that can cause poor antibody responses in chronic viral infections. The finding, published today (9 April) in the journal, Immunity, may lead to earlier intervention and possibly prevention of some types of viral infections such as HIV or hepatitis. One of the remaining mysteries of […]
New method developed to isolate HIV particles
Researchers at Leipzig University and Ulm University have developed a new method to isolate HIV from samples more easily, potentially making it easier to detect infection with the virus. They focus on peptide nanofibrils (PNFs) on magnetic microparticles, a promising tool and hybrid material for targeted binding and separation of viral particles. They have published […]
Researchers a step closer to a cure for HIV
By 2030, the World Health Organization (WHO), the Global Fund and UNAIDS are hoping to end the human immunodeficiency virus (HIV) and AIDS epidemic. An international team of researchers led by Eric Arts, professor at the Schulich School of Medicine & Dentistry, and Jamie Mann, senior lecturer at the University of Bristol (U.K.), has brought […]
COVID-19 virus can stay in the body more than a year after infection
The COVID-19 virus can persist in the blood and tissue of patients for more than a year after the acute phase of the illness has ended, according to new research from UC San Francisco that offers potential clues to why some people develop long COVID. The scientists found pieces of SARS-CoV-2, referred to as COVID […]
